TMPRSS9

transmembrane serine protease 9, the group of Type II transmembrane serine proteases

Basic information

Region (hg38): 19:2360238-2426261

Links

ENSG00000178297NCBI:360200OMIM:610477HGNC:30079Uniprot:Q7Z410AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TMPRSS9 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMPRSS9 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
2
clinvar
5
missense
105
clinvar
15
clinvar
3
clinvar
123
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 1 105 18 5

Variants in TMPRSS9

This is a list of pathogenic ClinVar variants found in the TMPRSS9 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-2389806-C-T Benign (Dec 26, 2018)743473
19-2389816-G-A not specified Likely benign (Aug 26, 2022)2309087
19-2389833-G-C Likely benign (Feb 01, 2023)2648970
19-2389868-C-G not specified Uncertain significance (Oct 05, 2023)3179990
19-2389868-C-T not specified Likely benign (Aug 09, 2021)2298572
19-2389903-G-A not specified Likely benign (Nov 09, 2024)3458922
19-2396575-C-T not specified Uncertain significance (Apr 15, 2024)3327382
19-2396582-G-C not specified Uncertain significance (Oct 03, 2024)3458941
19-2396587-G-A not specified Uncertain significance (Feb 08, 2023)2472290
19-2396589-G-A not specified Uncertain significance (Dec 14, 2022)2334909
19-2396595-C-T not specified Uncertain significance (Aug 10, 2021)2347378
19-2396611-T-C not specified Uncertain significance (Oct 07, 2024)3458943
19-2396614-G-A not specified Likely benign (Jun 27, 2023)2594939
19-2396627-G-A not specified Likely benign (Nov 09, 2024)3458947
19-2396641-C-T not specified Uncertain significance (Jul 19, 2023)2602764
19-2396647-C-T not specified Uncertain significance (Oct 01, 2024)3458917
19-2399056-A-G not specified Uncertain significance (Aug 27, 2024)3458937
19-2399091-G-A not specified Uncertain significance (Jul 06, 2021)2209922
19-2399095-T-A not specified Uncertain significance (May 18, 2023)2548387
19-2399112-C-G not specified Uncertain significance (Aug 30, 2021)2359458
19-2399116-G-A not specified Likely benign (Mar 27, 2023)2569100
19-2399125-G-A not specified Likely benign (Mar 06, 2023)2494368
19-2399169-A-G not specified Uncertain significance (May 01, 2024)3327384
19-2401989-C-T not specified Uncertain significance (Jul 26, 2024)3458911
19-2402007-T-C not specified Likely benign (Mar 25, 2024)3327379

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TMPRSS9protein_codingprotein_codingENST00000332578 1736469
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.62e-170.48112532124251257480.00170
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.227446561.130.00004316647
Missense in Polyphen285256.141.11272596
Synonymous-1.793362971.130.00002132279
Loss of Function1.733345.60.7230.00000247479

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001970.00193
Ashkenazi Jewish0.0003130.000298
East Asian0.001040.00103
Finnish0.0007110.000647
European (Non-Finnish)0.002630.00245
Middle Eastern0.001040.00103
South Asian0.001960.00190
Other0.001030.000978

dbNSFP

Source: dbNSFP

Function
FUNCTION: Serase-1 and serase-2 are serine proteases that hydrolyze the peptides N-t-Boc-Gln-Ala-Arg-AMC and N-t-Boc-Gln- Gly-Arg-AMC. In contrast, N-t-Boc-Ala-Phe-Lys-AMC and N-t-Boc-Ala- Pro-Ala-AMC are not significantly hydrolyzed.;

Intolerance Scores

loftool
0.0742
rvis_EVS
1.65
rvis_percentile_EVS
96.19

Haploinsufficiency Scores

pHI
0.0712
hipred
N
hipred_score
0.219
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.188

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Tmprss9
Phenotype

Gene ontology

Biological process
proteolysis
Cellular component
integral component of plasma membrane
Molecular function
serine-type endopeptidase activity